Cancer cells often rely on specific protein complexes—groups of proteins that work together—to grow and survive. Dr. Jeong is using a new chemical technology called Molecular COUPLrs to identify and disable these disease-related protein complexes in lung cancer. This approach is especially relevant for non–small cell lung cancer, as well as for lung cancer brain metastases, which remain the leading cause of death for patients. By mapping which protein complexes each tumor depends on and finding ways to selectively disrupt them, Dr. Jeong aims to uncover new vulnerabilities in lung cancer and help lay the foundation for more effective treatments. Dr. Jeong received his PhD from Stanford University, Stanford, and his BS from Seoul National University, Seoul.